121 related articles for article (PubMed ID: 28124900)
1. TAT-Modified Gold Nanoparticle Carrier with Enhanced Anticancer Activity and Size Effect on Overcoming Multidrug Resistance.
Wang RH; Bai J; Deng J; Fang CJ; Chen X
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5828-5837. PubMed ID: 28124900
[TBL] [Abstract][Full Text] [Related]
2. The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.
Jiang Y; Wang Z; Duan W; Liu L; Si M; Chen X; Fang CJ
Nanoscale; 2020 Aug; 12(31):16451-16461. PubMed ID: 32790812
[TBL] [Abstract][Full Text] [Related]
3. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles.
Pan L; Liu J; He Q; Wang L; Shi J
Biomaterials; 2013 Apr; 34(11):2719-30. PubMed ID: 23337327
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
5. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
7. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
8. All-in-one nanosponge with pluronic shell for synergistic anticancer therapy through effectively overcoming multidrug resistance in cancer.
Lee JS; Hwang Y; Oh H; Sung D; Tae G; Choi WI
Nanomedicine; 2022 Feb; 40():102486. PubMed ID: 34748960
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells.
Gopisetty MK; Kovács D; Igaz N; Rónavári A; Bélteky P; Rázga Z; Venglovecz V; Csoboz B; Boros IM; Kónya Z; Kiricsi M
J Nanobiotechnology; 2019 Jan; 17(1):9. PubMed ID: 30670028
[TBL] [Abstract][Full Text] [Related]
10. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
Wang F; Jiang X; Yang DC; Elliott RL; Head JF
Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
[TBL] [Abstract][Full Text] [Related]
12. TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors.
Song S; Gui L; Feng Q; Taledaohan A; Li Y; Wang W; Wang Y; Wang Y
Int J Nanomedicine; 2020; 15():6659-6671. PubMed ID: 32982225
[TBL] [Abstract][Full Text] [Related]
13. TAT-modified nanosilver for combating multidrug-resistant cancer.
Liu J; Zhao Y; Guo Q; Wang Z; Wang H; Yang Y; Huang Y
Biomaterials; 2012 Sep; 33(26):6155-61. PubMed ID: 22682937
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Tandem Apoptosis for Overcoming Multidrug-Resistant Cancer.
Cho MH; Kim S; Lee JH; Shin TH; Yoo D; Cheon J
Nano Lett; 2016 Dec; 16(12):7455-7460. PubMed ID: 27960458
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of negative-charged nanoparticles assisted by ultrasound on the reversal multidrug resistance phenotype in breast cancer cells.
Wang D; Luo W; Wen G; Yang L; Hong S; Zhang S; Diao J; Wang J; Wei H; Li Y; Wang Y
Ultrason Sonochem; 2017 Jan; 34():448-457. PubMed ID: 27773267
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells.
Shen Q; Qiu L
J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
19. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
[TBL] [Abstract][Full Text] [Related]
20. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
